拉夫米定 的英文怎麼說

中文拼音 [lāfūmǐdìng]
拉夫米定 英文
lamivudine
  • 拉 : 拉構詞成分。
  • 米 : Ⅰ名詞1. （稻米） rice 2. （泛指去殼或皮的可吃的種子） shelled or husked seed 3. （姓氏） a surname Ⅱ量詞（公制長度的主單位） metre
  • 定 : Ⅰ形容詞1 （平靜; 穩定） calm; stable 2 （已經確定的; 不改變的） fixed; settled; established Ⅱ動詞...
  • 拉夫 : [舊時用語] press-gang; press people into service
  1. Eventually, htway htway s doctor decides in favour of a fourth option : to use azt, 3tc and nvp in syrup formulations

    最後，韋韋的醫生決定採取第四個方案，選用多夫定、拉米夫定及奈韋拉平的糖漿制劑。
  2. Choosing the correct arv regimen for htway htway will not be easy for her doctor. a third option would be to use a combination of azt, 3tc and abacavir, as recommended by who for hiv tb co - infection

    第三種方案是採用內含多夫定（ azt ） 、拉米夫定及阿巴卡韋（ abacavir ） 、適用於同時感染愛滋病與結核病的復合療法。
  3. As first - line, xolani was taking zidovudine, lamivudine and nevirapine. because azt and 3tc come in a fixed - dose combination, this means he was taking two pills twice daily. xolani s second - line treatment will consist of didanosine, ritonavir - boosted lopinavir lpv r, and tenofovir

    素拉利原本服用的第一線藥物包含多夫定（ azt ） 、拉米夫定（ 3tc ）及奈韋拉平（ nvp ） ，其中多夫定及拉米夫定是固定劑量組合，也是說，他原本每天只需服藥兩次，每次兩顆藥丸。
  4. Glaxosmithkline does market 3tc in china - but only combined with another drug, azt, as a dual therapy fdc tablet, or in a dosage which is suitable for treating hepatitis b but not recommended for hiv aids. the lack of access to a generic triple fdc forces msf and others to pay five times more for first - line arv treatment in china than in cambodia

    葛蘭素在中國銷售拉米夫定，但只與另一種成分多夫定製成的二合一固定劑量組合，而非較理想的三合一固定劑量組合，亦沒有適合治療愛滋病的劑量，只有醫治乙型肝炎病人的劑量。
  5. Therapy effects of short - term lamivudine treatment on 22 hepa - titis b patients with hbeag - negative

    拉米夫定治療兒童和青少年慢性乙型肝炎的長期臨床觀察
  6. The objective of this study was to assess the efficacy and safety of adefovir dipivoxil / adv ( hepsera ) therapy under compassionate use in patients with chronic hepatitis b ( chb ) and lamivudine resistance

    本文的目的就是研究阿德福偉在對拉米夫定耐藥的慢性乙肝患者當中使用的安全性和有效性。
  7. A 59 - year - old man receiving long - term lamivudine therapy experienced a fatal exacerbation of hepatitis b virus ( hbv ) infection resulting in hepatic necrosis following the emergence of variant hbv

    一例長期使用拉米夫定治療的59歲男性患者在hbv變異株出現后乙肝病毒感染發生致命性加重，導致肝壞死。
  8. 5. the mpcr - rflp assay was useful for its reliability in monitoring hbv ymdd mutants. melting curve assay and pcr microplate hybridization - elisa assay should be further improved to increase their sensitivity and specialty

    5 . mpcr一rflp法檢測ymdd突變株具有較好的可靠性和可行性，是監測拉米夫定耐藥株的一種非常有效的方法;熔解曲線法和pcr微板核酸雜交法需要進一步完善以提高敏感性和特異性。
  9. Hbv genotype was determined by the restriction fragment length polymorphism analysis in patients with chronic hbv infection in 5 cities of fujian province. 2. the sensitivities and specialties of melting curve assay and pcr microplate hybridization - elisa assay were compared with mpcr - rflp and sequence analysis for the detection of hbv ymdd mutants in 44 serums from patients receiving lamivudine monitherapy with viral breakthrough

    應用熔解曲線法和pcr微板核酸雜交- elisa法對44例接受拉米夫定治療過程中出現病毒學反跳時的血清進行ymdd突變株的檢測，並與測序法和mpcr - rflp法比較它們的敏感性、一致性。
  10. Lamivudine therapy for children and teenagers with chronic hepatitis b : a long term clinical observation

    復方甘草酸苷聯合拉米夫定治療慢性乙型肝炎的臨床研究
  11. Conclusion : low - dose im hbig plus lamivudine provides safe and effective long - term prophylaxis against recurrent hbv at < 10 % the cost of the high - dose regimen

    結論：低劑量肌注乙型肝炎免疫球蛋白聯合拉米夫定的使用為長時間的預防hbv復發提供了安全有效的方案並且可使花費小於大劑量用藥方案費用的10 % 。
  12. Methods : sets of 3 liver biopsies, from 63 patients before and after 1 year of randomized lamivudine treatment and after 2 years of further open - label treatment, were assigned histologic activity index scores under code

    方法:制定三次肝臟穿刺， 63名病人，任選， 1年前，一年後，兩年後（開封）拉米夫丁治療.三次肝穿的紀錄結果是編碼保密的
  13. Short - term effect of lamivudine with gan bi tuo treatment in patients with hepatits b

    拉米夫定聯合苷必妥治療慢性乙型肝炎病人的近期療效
  14. Clinical observation of lamivudine therapy in 50 patients with chronic hepatitis b infection

    拉米夫定治療中國慢性乙型肝炎病人2年的臨床研究
  15. Background & aims : adefovir monotherapy is an established treatment modality for lamivudine - experienced patients with chronic hepatitis b, but it carries a significant risk of resistance in the long term

    背景與目的：對于拉米夫定治療過的慢性乙肝患者，用阿德福韋酯單藥治療是一種明確的治療模式，但是從長遠觀點來看，這會帶來嚴重的耐藥風險。
  16. 《 international hepatis 》 ： aasld guideline don ' t suggest lamivudine as naive, but in china lamivudine is the classical drug, what do you think of it

    國際肝病： aasld指南不推薦拉米夫定作為初始核苷類治療藥物，但是在中國，拉米夫定是經典的抗病毒藥物，你怎麼認為？
  17. The rate of hepatitis b virus resistance to adefovir dipivoxil and the evolution of hepatitis b virus in lamivudine - resistant chronic hepatitis b patients with adv monotherapy

    阿德福韋治療拉米夫定耐藥慢性乙型肝炎患者的耐藥率及耐藥株進化情況
  18. Prognosis of chronic hepatitis b has been improved significantly because of the clinical application of nucleoside / nucleotide analogues, such as lamivudine, adefovir dipivoxil, entecavir

    拉米夫定、阿德福韋酯和恩替卡韋等核苷/核苷酸類似物的臨床應用，大大改善了慢性乙型肝炎的預后。
  19. Lindsay kl. introduction to therapy and hepatitis c. hepatology, 2002, 36 ( suppl ) : s114 - 120, s121 - 127, s135 - 144

    姚光弼.正確認識和評價拉米夫定在治療慢性乙型肝炎中的地位.肝臟， 2002 ， 7 : 73 - 74
  20. Fraser gray, who leads glaxo ' s lamivudine development team, said he was not aware of any unha ine among asian researchers over the company ' s interpretation of their data

    梁說，葛蘭素盡力想掩蓋對拉米夫定的擔憂，將她的名字附在未經其本人同意的樂觀的研究報告上，並編造了大量資料來掩蓋該病的問題。
分享友人
分享到 Line

分享到臉書